Genetic status determines 18 F-FDG uptake in pheochromocytoma/paraganglioma

Germline mutations and genotype–phenotype correlation in Asian Indian patients with pheochromocytoma and paraganglioma

(2016) Reshma Pandit et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

68Ga-DOTATATE and 18F-FDG PET/CT in Paraganglioma and Pheochromocytoma: utility, patterns and heterogeneity

(2016) Chian A. Chang et al.   CANCER IMAGING

Moving Beyond "Lumpology": PET/CT Imaging of Pheochromocytoma and Paraganglioma

(2015) M. S. Hofman et al.   CLINICAL CANCER RESEARCH

Superiority of [68Ga]-DOTATATE PET/CT to Other Functional Imaging Modalities in the Localization of SDHB-Associated Metastatic Pheochromocytoma and Paraganglioma

(2015) I. Janssen et al.   CLINICAL CANCER RESEARCH

68Ga-DOTATATE PET/CT in the Localization of Head and Neck Paragangliomas Compared with Other Functional Imaging Modalities and CT/MRI

(2015) I. Janssen et al.   JOURNAL OF NUCLEAR MEDICINE

Current views on cell metabolism in SDHx-related pheochromocytoma and paraganglioma

(2014) Ales Vicha et al.   ENDOCRINE-RELATED CANCER

18F-FDG PET/CT as a predictor of hereditary head and neck paragangliomas

(2014) Elise M. Blanchet et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Pheochromocytoma and Paraganglioma: An Endocrine Society Clinical Practice Guideline

(2014) Jacques W. M. Lenders et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

DIAGNOSIS OF ENDOCRINE DISEASE: Biochemical diagnosis of phaeochromocytoma and paraganglioma

(2013) A van Berkel et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Modern Nuclear Imaging for Paragangliomas: Beyond SPECT

(2012) D. Taieb et al.   JOURNAL OF NUCLEAR MEDICINE

Staging and Functional Characterization of Pheochromocytoma and Paraganglioma by 18F-Fluorodeoxyglucose (18F-FDG) Positron Emission Tomography

(2012) Henri J. L. M. Timmers et al.   JNCI-Journal of the National Cancer Institute

Warburg Effect’s Manifestation in Aggressive Pheochromocytomas and Paragangliomas: Insights from a Mouse Cell Model Applied to Human Tumor Tissue

(2012) Stephanie M. J. Fliedner et al.   PLoS One

Updated and New Perspectives on Diagnosis, Prognosis, and Therapy of Malignant Pheochromocytoma/Paraganglioma

(2012) Gabriele Parenti et al.   Journal of Oncology

Catecholamine metabolomic and secretory phenotypes in phaeochromocytoma

(2010) G. Eisenhofer et al.   ENDOCRINE-RELATED CANCER

Genetics of Pheochromocytoma and Paraganglioma in Spanish Patients

(2009) Alberto Cascón et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Comparison of18F-Fluoro-L-DOPA,18F-Fluoro-Deoxyglucose, and18F-Fluorodopamine PET and123I-MIBG Scintigraphy in the Localization of Pheochromocytoma and Paraganglioma

(2009) Henri J. L. M. Timmers et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Clinically Guided Genetic Screening in a Large Cohort of Italian Patients with Pheochromocytomas and/or Functional or Nonfunctional Paragangliomas

(2009) Massimo Mannelli et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

18F-FDG Avidity of Pheochromocytomas and Paragangliomas: A New Molecular Imaging Signature?

(2009) D. Taieb et al.   JOURNAL OF NUCLEAR MEDICINE

Predictive Value of 18F-FDG PET and Somatostatin Receptor Scintigraphy in Patients with Metastatic Endocrine Tumors

(2009) E. Garin et al.   JOURNAL OF NUCLEAR MEDICINE

The Warburg Effect Is Genetically Determined in Inherited Pheochromocytomas

(2009) Judith Favier et al.   PLoS One